CVNA (NASDAQ: CVNA) option exercise and three 10b5-1 sales of 10,000 shares

Rhea-AI Filing Summary

CVNA reported the sale/transfer of 10,000 shares of Common Stock on 04/01/2026 executed via an exercise of stock options for cash. The filing also lists three prior 10b5-1 sales of 10,000 shares each on 03/02/2026, 02/02/2026, and 01/02/2026, with proceeds shown for each sale.

Insights

Securities Compliance Analyst

Rule 144 notice of an option exercise and multiple 10b5-1 sales; routine disclosure.

The filing documents a 10,000-share issuance on 04/01/2026 tied to an exercise of stock options with cash consideration. It also lists three monthly 10b5-1 sales of 10,000 shares each in 01/02/2026, 02/02/2026, and 03/02/2026, with dollar proceeds recorded.

These are procedural compliance disclosures under transfer restrictions and trading-plan rules; cash‑flow recipients and any holding-period conditions are shown in the entries. Subsequent filings would show final transfer clearance or additional plan activity.

Corporate Actions Specialist

Exercise plus serial planned sales visible; no material operational impact disclosed.

The record shows an option exercise reported as an issuer action and recurring monthly 10b5-1 plan transactions of equal size. Dollar figures for each sale are included, indicating executed transactions rather than mere authorizations.

Because these entries document transfers and planned-sales execution, their investor relevance is limited to disclosure of insider/affiliate liquidity; they do not by themselves change company financials.

Key Figures

Shares sold on 04/01/2026: 10,000 shares 10b5-1 sale on 03/02/2026: 10,000 shares 10b5-1 sale on 02/02/2026: 10,000 shares +3 more

6 metrics

Shares sold on 04/01/2026 10,000 shares Exercise of stock options (issuer entry)

10b5-1 sale on 03/02/2026 10,000 shares Proceeds listed as $3,226,689.00

10b5-1 sale on 02/02/2026 10,000 shares Proceeds listed as $4,112,724.00

10b5-1 sale on 01/02/2026 10,000 shares Proceeds listed as $4,019,355.00

Securities line amount $3,143,800.00 Numeric entry present in the securities information row

Identifier/record number 142736197 Numeric entry in filer information section

Key Terms

10b5-1 Sales Plan, Exercise of Stock Options, Form 144

3 terms

10b5-1 Sales Plan regulatory

"10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway"

Exercise of Stock Options financial

"Exercise of Stock Options | Issuer | 10000 | 04/01/2026 | Cash"

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10000	3143800.00	142736197	04/01/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/01/2026	Exercise of Stock Options	Issuer			10000	04/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ 85281	COMMON	03/02/2026	10000	3226689.00
10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ 85281	COMMON	02/02/2026	10000	4112724.00
10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ 85281	COMMON	01/02/2026	10000	4019355.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CVNA's Form 144 disclose about the 04/01/2026 transaction?

The filing discloses a 10,000-share transaction on 04/01/2026 executed via an exercise of stock options for cash, recorded under the issuer entry.

Does the CVNA filing show other recent sales by affiliated holders?

Yes. The filing lists three prior 10b5-1 sales of 10,000 shares each on 01/02/2026, 02/02/2026, and 03/02/2026, with proceeds shown next to each entry.

Who executed the 04/01/2026 exercise and where was it reported?

The exercise is recorded under an issuer entry for Common Stock and shows execution through Morgan Stanley Smith Barney LLC Executive Financial Services at a New York address.

What proceeds are reported for the recent 10b5-1 sales in the filing?

The filing shows proceeds of $4,019,355.00, $4,112,724.00, and $3,226,689.00 associated with the 01/02/2026, 02/02/2026, and 03/02/2026 10b5-1 sales respectively.